December 16, 2021

CRISPR innovation hits the gas

Biocentury More
January 15, 2020

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Xconomy More
January 15, 2020

Fifth Emendo-ment: Next-wave gene editing process gets its due, eminent in domain as more board the Omni-bus

Bio World More
January 15, 2020

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Xconomy More
January 15, 2020

Takeda hops onto $61M round for CRISPR player synthesizing Cas9 alternatives

Endpoint News More
January 15, 2020

Emendo raises $61M to build on Takeda-partnered gene editing platform

FierceBiotech More
January 15, 2020

Gene editing co Emendo Biotherapeutics raises $61m

Globes More
close